This RFP supports projects specifically in renal cell carcinoma that:
- Increase understanding of the rationale for consideration of IO combination therapies in the treatment of RCC including IO/VEGFR TKI and IO/IO
- Increase awareness of when immunotherapy should be considered as a treatment option for patients with RCC to include patient selection, optimal drug combinations, and sequencing
- Improve the early detection and management of IO and IO combination (IO/VEGFR TKI or IO/IO) related adverse events in RCC patients.
Funding & Duration
The typical grant maximum under this RFP will be up to USD $250,000 (approx. AUD $354,000). However larger proposals will be considered for funding if they include a broad geography and multiple activities such as several live events, enduring activities, and supportive materials and tools.
Smaller educational proposals are also encouraged. Organisations that would like to develop activities for a more limited regional or local group of healthcare providers should also apply. Typically grant amounts for local or regional activities should not exceed around USD $50,000 (approx. AUD $71,000)
The following may apply:
- medical, nursing, allied health, and/or pharmacy professional schools;
- healthcare institutions (both large and small); professional associations and medical societies;
- medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
If the project involves multiple departments within an institution and/or between different institutions / organisations / associations, all institutions must have a relevant role and the requesting organisation must have a key role in the project.
For projects offering continuing education credit, the requesting organisation must be accredited.
Submission Requirements & Due Date
- Applications must be submitted for internal review by 4 April 2019
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review